A newly published analysis by a research team at Southern Illinois University School of Medicine has teased out some additional information about the well-recognized increase in the incidence of neuroendocrine forms of prostate cancer over the past 20 or so years. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: carcinoma, incidence, mortality, neuroendocrine, small cell, survival | Leave a comment »
A sophisticated presentation at the annual meeting of the American Society of Clinical Oncology today (on behalf of the West Coast Prostate Cancer “Dream Team”) gave us insights into the the development of neuroendocrine forms of drug-resistant prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: histology, intermediate, neuroendocrine, small cell | 1 Comment »
A new review article in the open access journal Oncology offers some key information about neuroendocrine (small-cell) carcinomas of the prostate (and why they offer essential lessons about the diagnosis and management of prostate cancer). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, Management, neuroendocrine, risk, small cell | 1 Comment »
Small cell carcinoma (SCC) of the prostate is a rare but particularly aggressive and nasty form of prostate cancer. (It can also be found in other genitourinary organs, such as the bladder and the adrenal glands.) … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: SCC, small cell | Leave a comment »
Small cell carcinoma of the prostate or SCCP is a rare, aggressive, and treatment-refractory form of prostate cancer. No good form of treatment is yet known for this disease, and median survival from initial diagnosis is less than 2 years. … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: carcinoma, cisplatin, cisplatinum, irinotecan, small cell | 3 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 